IL13 and infection: Importantly, there was a statistically significant decrease in the number of IL-13+ ILC2s in the groups receiving TSLP neutralizing antibody at either 6 or 36 hours after infection compared with RSV-infected mice treated with isotype control antibody (Fig 3, J).